Although during our literature search, we found that most studies on the relationship between serum IGF-1 and hemoglobin in patients with CKD or on dialysis were published in the late 20th and early 21st centuries, no study has yet to show that exogenous IGF-1 preparations can improve anemia in this population. The gene discussed is IGF1; the disease is anemia.